Helicobacter pylori infection and acute myocardial infarction

Dario Nakić1, Aleksandar Vcev, Albino Jović

  • 1General Hospital Zadar, Department of Internal Medicine, Zadar, Croatia. dario.nakic@zd.t-com.hr

Collegium Antropologicum
|November 8, 2011
PubMed

Insights

Helicobacter pylori infection may not be an independent risk factor for acute myocardial infarction (AMI). However, H. pylori seropositivity was linked to increased AMI risk in patients with multiple risk factors, including lower blood pressure and controlled diabetes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) infection is a common bacterial pathogen.
  • Its potential role in cardiovascular diseases, including acute myocardial infarction (AMI), remains under investigation.
  • Understanding risk factors for AMI is crucial for public health.

Purpose of the Study:

  • To investigate if H. pylori infection is an independent risk factor for AMI.
  • To determine the association between H. pylori infection and the severity of AMI.
  • To explore potential interactions between H. pylori status and other cardiovascular risk factors.

Main Methods:

  • Prospective, single-center study.
  • 100 patients diagnosed with AMI and 93 healthy controls were enrolled.
  • H. pylori seropositivity was assessed, and disease severity was evaluated.

Main Results:

  • No significant difference in H. pylori seropositivity between AMI patients (29%) and controls (26%).
  • No significant association found between H. pylori infection and AMI severity.
  • A significant association was observed in patients with three or more risk factors: H. pylori seropositive individuals with lower blood pressure and better-controlled diabetes had a higher AMI risk.

Conclusions:

  • H. pylori infection may not be a direct independent risk factor for AMI in the general population.
  • H. pylori seropositivity could be a contributing factor to AMI risk in specific subgroups of patients with multiple comorbidities.
  • Further large-scale, multicenter trials are necessary to elucidate the precise role of H. pylori in AMI development.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...